146 related articles for article (PubMed ID: 36302938)
1. Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC.
Hindocha S; Charlton TG; Linton-Reid K; Hunter B; Chan C; Ahmed M; Greenlay EJ; Orton M; Bunce C; Lunn J; Doran SJ; Ahmad S; McDonald F; Locke I; Power D; Blackledge M; Lee RW; Aboagye EO
NPJ Precis Oncol; 2022 Oct; 6(1):77. PubMed ID: 36302938
[TBL] [Abstract][Full Text] [Related]
2. A comparison of machine learning methods for predicting recurrence and death after curative-intent radiotherapy for non-small cell lung cancer: Development and validation of multivariable clinical prediction models.
Hindocha S; Charlton TG; Linton-Reid K; Hunter B; Chan C; Ahmed M; Robinson EJ; Orton M; Ahmad S; McDonald F; Locke I; Power D; Blackledge M; Lee RW; Aboagye EO
EBioMedicine; 2022 Mar; 77():103911. PubMed ID: 35248997
[TBL] [Abstract][Full Text] [Related]
3. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
4. Application and limitation of radiomics approach to prognostic prediction for lung stereotactic body radiotherapy using breath-hold CT images with random survival forest: A multi-institutional study.
Kakino R; Nakamura M; Mitsuyoshi T; Shintani T; Kokubo M; Negoro Y; Fushiki M; Ogura M; Itasaka S; Yamauchi C; Otsu S; Sakamoto T; Sakamoto M; Araki N; Hirashima H; Adachi T; Matsuo Y; Mizowaki T
Med Phys; 2020 Sep; 47(9):4634-4643. PubMed ID: 32645224
[TBL] [Abstract][Full Text] [Related]
5. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
Mes SW; van Velden FHP; Peltenburg B; Peeters CFW; Te Beest DE; van de Wiel MA; Mekke J; Mulder DC; Martens RM; Castelijns JA; Pameijer FA; de Bree R; Boellaard R; Leemans CR; Brakenhoff RH; de Graaf P
Eur Radiol; 2020 Nov; 30(11):6311-6321. PubMed ID: 32500196
[TBL] [Abstract][Full Text] [Related]
6. Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy.
Li Q; Kim J; Balagurunathan Y; Liu Y; Latifi K; Stringfield O; Garcia A; Moros EG; Dilling TJ; Schabath MB; Ye Z; Gillies RJ
Med Phys; 2017 Aug; 44(8):4341-4349. PubMed ID: 28464316
[TBL] [Abstract][Full Text] [Related]
7. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
[TBL] [Abstract][Full Text] [Related]
8. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
10. Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging.
Oliveira C; Amstutz F; Vuong D; Bogowicz M; Hüllner M; Foerster R; Basler L; Schröder C; Eboulet EI; Pless M; Thierstein S; Peters S; Hillinger S; Tanadini-Lang S; Guckenberger M
EJNMMI Res; 2021 Aug; 11(1):79. PubMed ID: 34417899
[TBL] [Abstract][Full Text] [Related]
11. Radiomics Model Based on Gadoxetic Acid Disodium-Enhanced MR Imaging to Predict Hepatocellular Carcinoma Recurrence After Curative Ablation.
Zhang L; Cai P; Hou J; Luo M; Li Y; Jiang X
Cancer Manag Res; 2021; 13():2785-2796. PubMed ID: 33790652
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence.
van Timmeren JE; van Elmpt W; Leijenaar RTH; Reymen B; Monshouwer R; Bussink J; Paelinck L; Bogaert E; De Wagter C; Elhaseen E; Lievens Y; Hansen O; Brink C; Lambin P
Radiother Oncol; 2019 Jul; 136():78-85. PubMed ID: 31015133
[TBL] [Abstract][Full Text] [Related]
13. Radiomics for prediction of radiation-induced lung injury and oncologic outcome after robotic stereotactic body radiotherapy of lung cancer: results from two independent institutions.
Bousabarah K; Blanck O; Temming S; Wilhelm ML; Hoevels M; Baus WW; Ruess D; Visser-Vandewalle V; Ruge MI; Treuer H; Kocher M
Radiat Oncol; 2021 Apr; 16(1):74. PubMed ID: 33863358
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
[TBL] [Abstract][Full Text] [Related]
15. PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.
Yang L; Xu P; Li M; Wang M; Peng M; Zhang Y; Wu T; Chu W; Wang K; Meng H; Zhang L
Front Oncol; 2022; 12():894323. PubMed ID: 35800046
[TBL] [Abstract][Full Text] [Related]
16. Use of Radiomics Combined With Machine Learning Method in the Recurrence Patterns After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: A Preliminary Study.
Li S; Wang K; Hou Z; Yang J; Ren W; Gao S; Meng F; Wu P; Liu B; Liu J; Yan J
Front Oncol; 2018; 8():648. PubMed ID: 30622931
[No Abstract] [Full Text] [Related]
17. Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients.
Alfieri S; Romanò R; Bologna M; Calareso G; Corino V; Mirabile A; Ferri A; Bellanti L; Poli T; Marcantoni A; Grosso E; Tarsitano A; Battaglia S; Blengio F; De Martino I; Valerini S; Vecchio S; Richetti A; Deantonio L; Martucci F; Grammatica A; Ravanelli M; Ibrahim T; Caruso D; Locati LD; Orlandi E; Bossi P; Mainardi L; Licitra LF
Acta Oncol; 2021 Sep; 60(9):1192-1200. PubMed ID: 34038324
[TBL] [Abstract][Full Text] [Related]
18. Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma.
Haider SP; Zeevi T; Baumeister P; Reichel C; Sharaf K; Forghani R; Kann BH; Judson BL; Prasad ML; Burtness B; Mahajan A; Payabvash S
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635216
[TBL] [Abstract][Full Text] [Related]
19. CT-based radiomic features predict tumor grading and have prognostic value in patients with soft tissue sarcomas treated with neoadjuvant radiation therapy.
Peeken JC; Bernhofer M; Spraker MB; Pfeiffer D; Devecka M; Thamer A; Shouman MA; Ott A; Nüsslin F; Mayr NA; Rost B; Nyflot MJ; Combs SE
Radiother Oncol; 2019 Jun; 135():187-196. PubMed ID: 30961895
[TBL] [Abstract][Full Text] [Related]
20. A radiomics-based model for predicting prognosis of locally advanced gastric cancer in the preoperative setting.
Shin J; Lim JS; Huh YM; Kim JH; Hyung WJ; Chung JJ; Han K; Kim S
Sci Rep; 2021 Jan; 11(1):1879. PubMed ID: 33479398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
